Webbphlegmyheatclear group dose rats drug Prior art date 2024-07-07 Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal … WebbWhat is claimed is: 1. A composition comprising butyric acid or a salt thereof and Tamarindus indica extract. 2. The composition of claim 1, wherein the butyric acid salt is selected from the group consisting of calcium butyrate and sodium butyrate.

小青龙汤加减治疗慢性阻塞性肺病急性加重的临床观察-黄霞廖安平 …

WebbWhat is claimed is: 1. A composition comprising butyric acid or a salt thereof and Tamarindus indica extract. 2. The composition of claim 1, wherein the butyric acid salt is … Webb痰热清治疗对aecopd患者症状、血气、肺功能指标及炎性因子水平的影响*俞洋欧阳洋杨晓龙张学人朱辉(上海中医药大学附属曙光医院急诊内科上海201203)摘要目的：探究痰热清对慢性阻塞性肺疾病发作加重期(aecopd)患者的症状、血气、肺功能指标及炎症反应的影响。 highway secondary school performance

US Patent Application for APPLICATION OF …

WebbAbstract: Disclosed is a method for producing algae-derived polyunsaturated fatty acids, comprising the steps of a) contacting dry algae with ethanol; b) removing ethanol to … WebbAbstract: The invention discloses an application of phlegmyheatclear in preparation of a drug for treatment of acute exacerbation of chronic obstructive pulmonary disease. The … WebbPhlegmyheatclear preparation is prepared from several components, that is, scutellaria baicalensis, bear gall powder, cornu gorais, honeysuckle flowers and fructus forsythia. … highway secondary school